-
2022
-
APR.
Full acquisition of Samsung Bioepis
-
APR.
-
2021
-
DEC.
ISO Certification for Quality Management System
-
SEP.
Launch of the CDO process platform, S-Cellerate™
-
MAY.
Manufacturing Partnership with Moderna
for its COVID-19 vaccineGlobal ISO Certifications for BCMS, Energy,
Health & Safety, and Environmental Management -
APR.
10th Anniversary
-
DEC.
-
2020
-
NOV.
Manufacturing Partnership with Eli Lilly for its COVID-19 antibody treatment
Groundbreaking of Plant 4
-
OCT.
Opening of the San Francisco R&D Center
-
SEP.
Manufacturing Partnership with AstraZeneca
-
AUG.
Launch of proprietary cell line development platform,
S-CHOice® -
JUN.
Opening of Virtual Exhibition Hall
-
MAY.
ISO22301 Certification
Expanded Manufacturing Partnership with GSK
-
APR.
Manufacturing Partnership with Vir for its COVID-19 treatment
-
NOV.
-
2019
-
NOV.
ISO 27001 Certification
-
NOV.
-
2018
-
OCT.
AEO (Authorized Economic Operator) Certification
Plant 3 cGMP Ready
-
JUL.
Manufacturing Partnership with UCB
-
APR.
ISO 22301 Certification (BCMS, Business Continuity Management System)
-
OCT.
-
2017
-
DEC.
First Approval of Plant 2 by EMA
-
NOV.
Plant 3 Mechanical Completion
-
OCT.
MOU for Strategic Alliance with Merck (MSD)
-
SEP.
First Approval of Plant 2 by FDA
-
JUL.
Manufacturing Partnership with Sun Pharma
-
MAY.
First Approval of Plant 1 by PMDA
-
DEC.
-
2016
-
NOV.
Samsung Biologics IPO on KOSPI
-
JUL.
First Approval of Plant 1 by EMA
-
FEB.
Plant 2 DS cGMP Ready
-
NOV.
-
2015
-
NOV.
First Approval of Plant 1 by FDA
Plant 3 Construction Started
-
FEB.
Plant 2 Mechanical Completion
-
NOV.
-
2014
-
APR.
DP Manufacturing Partnership with BMS
-
APR.
-
2013
-
OCT.
Manufacturing Partnership with Roche
-
SEP.
Plant 2 Construction Started
-
AUG.
Plant 1 DP cGMP Ready
-
JUL.
Manufacturing Partnership with BMS
-
JUN.
Plant 1 DS cGMP Ready
-
OCT.
-
2012
-
JUL.
Plant 1 Mechanical Completion
-
JUL.
-
2011
-
MAY.
Plant 1 Construction Started
-
APR.
Foundation of Samsung Biologics
-
MAY.